Saint-Pierre Hospital
Brussels, 1000, Belgium
NCT Number: NCT03404011
The aim of this study is to evaluate the acute effect of propylene glycol and glycerol intake on cardiorespiratory blood parameters.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Brussels, 1000, Belgium
Background : Propylene glycol/glycerol intake is increasingly popular. Acute effect of propylene glycol and glycerol intake on cardiorespiratory blood parameters is unknown. The investigators postulate that intake of propylene glycol and glycerol could modifiy cardiorespiratory blood parameters.
Aims of this study : to test the following hypotheses :
To test this hypothesis, we will perform blood samples before and after intake of propylene glycol and glycerol. Participants will be tobacco smoker between 18 and 70 years old, with multiple cardiovascular risk factors, and who will undergo a cardiac catherization. After the cardiac catherization, the catheter will be used to perform serial blood samples.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intake of 1 gram of propylene glycol/Glycerol mix (50:50). Blood sample before, 5 minutes and 20 minutes after intake.
Mimicking propylene glycol/glycerol intake with the device turns off. Blood sample before, 5 minutes and 20 minutes after intake.
Time frame: 5 minutes
Blood sample
Time frame: 20 minutes
Blood sample
Université Libre de Bruxelles
Other
Acute Effects of Propylene Glycol/Glycerol Intake on Cardiorespiratory Blood Parameters
Acronym: AEPGGIBP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03864068
46, XX Disorders of Sex Development, Adnexal Diseases
Hershey, Pennsylvania, United States
View Trial DetailsNCT04865965
Behavior, Body Weight
Boston, Massachusetts, United States
View Trial DetailsNCT05488223
Body Weight, Child Obesity
Mexico City, Mexico
View Trial DetailsNCT05451992
Body Weight, Glucose Metabolism Disorders
Bari, BA, Italy
View Trial Details